Here is our Patient Power breaking news interview with principal investigator Dr. Ruben Mesa from Mayo Clinic about what the FDA hold on the pacritinib trials means for patients: Olnkd.in/btK5PGv
Expert Explanation on Pacritinib Trials Hold - MPN Voice
Expert Explanation on Pacritinib Trials Hold
Written by
andrewschorr
To view profiles and participate in discussions please or .
1 Reply
•
Thank you, Andrew. What would we do without Patient Power? Thank you for all the work you put into providing us with such invaluable information. Pacritinib was going to be my next step so this has all come as a bit of a shock. I feel for those already on it. It is a brave step to go into a clinical trial as, as we see, it is not all plain sailing. Maybe it's not the end of the road for Pacritinib. We will have to wait and see. Obviously patient safety has to take top priority
Jan
Not what you're looking for?
You may also like...
Good article on Pacritinib
com/articles/pacritinib-offers-new-option-for-patients-with-advanced-myelofibrosis
Thoughts on MAJIK trial outcomes
dosage of 6500mg / 13 tablets pw.
What I took from the paper, from a personal perspective, was:...
Leukaemia care/NHS antibody trial
else seen the NHS antibody trial for cancer patients, it came in an email from leukaemia care I...
Share Your Thoughts on Clinical Trials- Take Our Survey
officials. They know clinical trial participation is very low and they want to hear from patients...
Trial or not to Trial
are on or have been on a trial - please share any views about clinical trials that you might have.